Taken together, the combination of dysregulated metabolism and pro-inflammatory alterations generates a complex immunometabolic network in the bone marrow, which contributes to the pathogenesis of CHIP and MDS [10,18]. The gene discussed is STUB1; the disease is myelodysplastic syndrome.